1. Home
  2. GBIO vs UEIC Comparison

GBIO vs UEIC Comparison

Compare GBIO & UEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • UEIC
  • Stock Information
  • Founded
  • GBIO 2016
  • UEIC 1986
  • Country
  • GBIO United States
  • UEIC United States
  • Employees
  • GBIO N/A
  • UEIC N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • UEIC Consumer Electronics/Appliances
  • Sector
  • GBIO Health Care
  • UEIC Consumer Staples
  • Exchange
  • GBIO Nasdaq
  • UEIC Nasdaq
  • Market Cap
  • GBIO 165.5M
  • UEIC 150.4M
  • IPO Year
  • GBIO 2020
  • UEIC 1993
  • Fundamental
  • Price
  • GBIO $1.11
  • UEIC $10.56
  • Analyst Decision
  • GBIO Strong Buy
  • UEIC Strong Buy
  • Analyst Count
  • GBIO 2
  • UEIC 2
  • Target Price
  • GBIO $7.50
  • UEIC $14.50
  • AVG Volume (30 Days)
  • GBIO 425.8K
  • UEIC 51.3K
  • Earning Date
  • GBIO 11-06-2024
  • UEIC 02-13-2025
  • Dividend Yield
  • GBIO N/A
  • UEIC N/A
  • EPS Growth
  • GBIO N/A
  • UEIC N/A
  • EPS
  • GBIO N/A
  • UEIC N/A
  • Revenue
  • GBIO $18,582,000.00
  • UEIC $382,019,000.00
  • Revenue This Year
  • GBIO $212.74
  • UEIC N/A
  • Revenue Next Year
  • GBIO N/A
  • UEIC $5.38
  • P/E Ratio
  • GBIO N/A
  • UEIC N/A
  • Revenue Growth
  • GBIO 514.08
  • UEIC N/A
  • 52 Week Low
  • GBIO $0.75
  • UEIC $7.53
  • 52 Week High
  • GBIO $4.65
  • UEIC $14.20
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 34.72
  • UEIC 45.68
  • Support Level
  • GBIO $1.03
  • UEIC $10.21
  • Resistance Level
  • GBIO $1.12
  • UEIC $10.89
  • Average True Range (ATR)
  • GBIO 0.13
  • UEIC 0.39
  • MACD
  • GBIO 0.02
  • UEIC -0.19
  • Stochastic Oscillator
  • GBIO 55.56
  • UEIC 29.32

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About UEIC Universal Electronics Inc.

Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.

Share on Social Networks: